Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Characteristics and Predictors of Early and Late Cardiovascular Complications of Covid-19 Patients - the PoLoCOV-Study (Polish LONG-COVID Cardiovascular Study)

NCT05018052 is registered in ClinicalTrials.gov with Michal Chudzik as lead sponsor.

NCT NCT05018052
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05018052 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Characteristics and Predictors of Early and Late Cardiovascular Complications of Covid-19 Patients - the PoLoCOV-Study (Polish LONG-COVID Cardiovascular Study)
Lead sponsor
Michal Chudzik
Phase
Observational
Overall status
Unknown status
Start date
May 29, 2020
Completion date
September 30, 2022
Enrollment
1,900 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid19, long-covid